Some people must handle them cautiously or even refrain from taking them altogether
Common side effects were predominantly gastrointestinal, including nausea, diarrhea, constipation, and vomiting, primarily during dose escalation [45] [46]
I confirm that I am over 18 years of age, have read and understood the Research Use Only Disclaimer, and acknowledge that all products are purchased solely for lawful research purposes and are not intended for human or animal consumption
The highest risk was in semaglutide (HR=1.39), then liraglutide (HR=1.25)
Eliud Sifonte, a diabetes and metabolism endocrinologist affiliated with NYU Langone Health, told Flow Space
GLP-1 receptor agonists suppress appetite and slow gastric emptying, which commonly leads to rapid, substantial weight loss: often 1520% of total body weight within a year